Severity and treatment of cognitive impairment
With an increase in life expectancy in the population, the proportion of people with cognitive impairment (CI) increases. Modern neurology focuses on the milder forms of CI: moderate, mild, and subjective CI, which are more promising in terms of successful treatment and slowing down their progressio...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
IMA-PRESS LLC
2021-06-01
|
| Series: | Неврология, нейропсихиатрия, психосоматика |
| Subjects: | |
| Online Access: | https://nnp.ima-press.net/nnp/article/view/1587 |
| _version_ | 1827062789287444480 |
|---|---|
| author | Yu. A. Starchina V. V. Zakharov |
| author_facet | Yu. A. Starchina V. V. Zakharov |
| author_sort | Yu. A. Starchina |
| collection | DOAJ |
| description | With an increase in life expectancy in the population, the proportion of people with cognitive impairment (CI) increases. Modern neurology focuses on the milder forms of CI: moderate, mild, and subjective CI, which are more promising in terms of successful treatment and slowing down their progression. Age is the leading risk factor for CI, the prevalence of which in the general population of people aged over 65 years reaches 10–15%. The primary role in CI development is played by Alzheimer's disease, cerebrovascular diseases, mixed vascular-neurodegenerative process, and other types of neurodegenerative diseases, and all of them share some pathophysiological mechanisms. Correction of vascular risk factors plays a leading role in the treatment of pre-dementia stages of CI. The possibilities of using nimodipine in the therapy of CI are analyzed. |
| first_indexed | 2024-04-10T02:00:59Z |
| format | Article |
| id | doaj.art-7dcb32b339284ead8b966cecbd8049f5 |
| institution | Directory Open Access Journal |
| issn | 2074-2711 2310-1342 |
| language | Russian |
| last_indexed | 2025-02-18T20:01:26Z |
| publishDate | 2021-06-01 |
| publisher | IMA-PRESS LLC |
| record_format | Article |
| series | Неврология, нейропсихиатрия, психосоматика |
| spelling | doaj.art-7dcb32b339284ead8b966cecbd8049f52024-10-17T16:15:28ZrusIMA-PRESS LLCНеврология, нейропсихиатрия, психосоматика2074-27112310-13422021-06-0113311912410.14412/2074-2711-2021-3-119-1241146Severity and treatment of cognitive impairmentYu. A. Starchina0V. V. Zakharov1I.M. Sechenov First Moscow State Medical University (Sechenov University), Ministry of Health of RussiaI.M. Sechenov First Moscow State Medical University (Sechenov University), Ministry of Health of RussiaWith an increase in life expectancy in the population, the proportion of people with cognitive impairment (CI) increases. Modern neurology focuses on the milder forms of CI: moderate, mild, and subjective CI, which are more promising in terms of successful treatment and slowing down their progression. Age is the leading risk factor for CI, the prevalence of which in the general population of people aged over 65 years reaches 10–15%. The primary role in CI development is played by Alzheimer's disease, cerebrovascular diseases, mixed vascular-neurodegenerative process, and other types of neurodegenerative diseases, and all of them share some pathophysiological mechanisms. Correction of vascular risk factors plays a leading role in the treatment of pre-dementia stages of CI. The possibilities of using nimodipine in the therapy of CI are analyzed.https://nnp.ima-press.net/nnp/article/view/1587dementiacognitive impairment without dementiamild cognitive impairmentnear-moderate cognitive declinesubjective cognitive impairmentpreventiontreatmentnimodipine |
| spellingShingle | Yu. A. Starchina V. V. Zakharov Severity and treatment of cognitive impairment Неврология, нейропсихиатрия, психосоматика dementia cognitive impairment without dementia mild cognitive impairment near-moderate cognitive decline subjective cognitive impairment prevention treatment nimodipine |
| title | Severity and treatment of cognitive impairment |
| title_full | Severity and treatment of cognitive impairment |
| title_fullStr | Severity and treatment of cognitive impairment |
| title_full_unstemmed | Severity and treatment of cognitive impairment |
| title_short | Severity and treatment of cognitive impairment |
| title_sort | severity and treatment of cognitive impairment |
| topic | dementia cognitive impairment without dementia mild cognitive impairment near-moderate cognitive decline subjective cognitive impairment prevention treatment nimodipine |
| url | https://nnp.ima-press.net/nnp/article/view/1587 |
| work_keys_str_mv | AT yuastarchina severityandtreatmentofcognitiveimpairment AT vvzakharov severityandtreatmentofcognitiveimpairment |